Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Music therapy.
- Who it may be relevant to
- Registry conditions: Cancer (With or Without Metastasis). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The innovative nature of this project lies in the combination of three types of intervention: tobacco addiction treatment, music therapy and therapeutic education. Three disciplines that work together. 1. Tobacco addiction treatment: reducing consumption, quitting, 2. Music therapy: acting on emotions and reward circuits, 3. Therapeutic education: promoting independent healthy practices. Patients learn to use the soundtrack independently to help them manage withdrawal symptoms caused by reducing or stopping tobacco consumption. In this programme, patients play an active role on several levels: * working with the music therapist to create a personalised 'soundtrack'; * identifying situations in which music can help them manage withdrawal symptoms; * using music independently in their everyday lives. The music therapy protocol will be proposed in this study, the soundtrack is co-created by the music therapist and the patient based on the patient's musical tastes and needs. The fact that the patient can use the musical tool independently also gives them significant leverage in their withdrawal process, allowing them to act on withdrawal symptoms and the main factors contributing to relapse.
Detailed description
Music therapy could address the three elements mentioned above:
* add a practitioner other than the tobacco specialist, * increase the patient's perception of self-efficacy, * provide the patient with a personalised soundtrack that may have an effect on withdrawal symptoms associated with smoking cessation.
Music therapy could increase the chances of successful cessation. It therefore seems innovative to offer an educational intervention combining the tobacco specialist nurse and the music therapist, which would enable patients to use a musical tool co-developed with the music therapist independently at home. There are no data on the learning and use of such a tool to reinforce self-efficacy in managing smoking cessation. The analysis of the existing literature is poor in terms of music therapy and addiction and virtually non-existent in terms of tobacco addiction.
The objective is to evaluate the feasibility of an intervention combining tobacco addiction treatment and music therapy and its impact on smoking cessation symptoms in patients with cancer who smoke.
Interventions
- Other Music therapy
Music therapy sessions in addition to nursing consultations: creation of a soundtrack to listen to in order to help quit smoking
Primary outcome measures
- Proportion of patients who adhered to the supervised sessions, combining follow-up by a tobacco addiction nurse and follow-up in music therapy [Time frame: From baseline to month 6]
Secondary outcome measures (8)
- Tobacco use [Time frame: at baseline, at month 3, at month 6]
- Withdrawal symptoms [Time frame: at baseline, at month 3, at month 6]
- The craving [Time frame: at baseline, at month 3, at month 6]
- Motivation [Time frame: at baseline, at month3, at month 6]
- Confidence [Time frame: at baseline, at month 3, at month 6]
- Sense of personal competence [Time frame: at baseline, at month 3, at month 6]
- Symptoms of anxiety and depression [Time frame: at baseline, at month 3, at month 6]
- Describe adherence to independent listening in music therapy between T2 and T6. [Time frame: at baseline, at month 3 and at month 6]
Eligibility criteria
Inclusion criteria
- Patients over the age of 18
- Patients with tobacco-related or non-tobacco-related cancer (excluding blood cancer)
- Patients who smoke daily
- Patients wishing to begin a smoking cessation programme
- Patients with a prognosis of > 1 year
- Patients who have given their informed, written and express consent
- Patients affiliated with a French social security scheme
Exclusion criteria
- Patients with uncorrected hearing loss
- Patients with unstable psychiatric conditions
- Patients for whom regular follow-up is impossible for psychological, family, social or geographical reasons
- Patients under guardianship, curatorship or judicial protection
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
France · 1 center
- Institut Du Cancer de Montpellier — Montpellier
Publications
- Benowitz NL. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med. 2008 Apr;121(4 Suppl 1):S3-10. doi: 10.1016/j.amjmed.2008.01.015. PMID 18342164
- Jassem J. Tobacco smoking after diagnosis of cancer: clinical aspects. Transl Lung Cancer Res. 2019 May;8(Suppl 1):S50-S58. doi: 10.21037/tlcr.2019.04.01. PMID 31211105
- Kathuria H, Neptune E. Primary and Secondary Prevention of Lung Cancer: Tobacco Treatment. Clin Chest Med. 2020 Mar;41(1):39-51. doi: 10.1016/j.ccm.2019.10.002. PMID 32008628
- Tabac. (https://www.who.int/fr/news-room/fact-sheets/detail/tobacco). Accessed 7 December 2023.
- Tabac - Réduire les risques de cancer. (https://www.e-cancer.fr/Comprendre-prevenir-depister/Reduire-les-risques-de-cancer/Tabac). Accessed 15 December 2023.
Identifiers
NCT: NCT07198971 · PROICM 2025-02 TEM